Ambry Becomes CSP for Roche NimbleGen Offerings | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Ambry Genetics has been named a certified service provider for several product offerings from Roche NimbleGen.

Aliso Viejo, Calif.-based Ambry will offer services using Nimblegen's comparative genomic hybridization, chromatin immunoprecipitation-on-chip, DNA methylation, and gene expression tools. The addition of these applications means that Ambry is now certified on all Roche NimbleGen applications, Roche said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.